PRAX nearly doubled its balance sheet size with stockholders' equity growing 97% to $878M, but R&D expenses surged 75% and operating cash burn worsened dramatically from -$132M to -$249M.
The massive balance sheet expansion suggests a significant equity raise that provided substantial new capital, but the company is burning through cash at an accelerated rate with operating losses deepening 63%. The increased share count from 20.2M to 27.9M shares confirms dilutive equity financing, while the doubling of current liabilities indicates growing operational obligations that investors should monitor closely.
PRAX experienced dramatic growth across all balance sheet metrics with total assets nearly doubling to $938M and cash increasing 66% to $357M, indicating a major capital raise during the period. However, the company's cash burn accelerated significantly with operating cash flow deteriorating 89% to -$249M and R&D expenses surging 75% to $267M, reflecting aggressive investment in their CNS pipeline. While the capital infusion provides runway, the accelerating burn rate and 38% share count increase signal meaningful dilution for existing shareholders, creating a mixed picture of expanded resources but intensifying operational cash demands.
Equity base grew 97.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Asset base grew 94.1% — expansion through organic growth, acquisitions, or capital deployment.
Operating cash flow fell 89% — earnings quality concerns; investigate working capital changes and non-cash items.
R&D investment increased 75.3% — signals commitment to future product development, though near-term margin impact.
Net income declined 65.9% — review whether driven by operations, interest costs, or non-recurring items.
Cash position surged 65.9% — strong cash generation or capital raise providing significant financial cushion.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Current liabilities surged 59.2% — significant near-term obligations; verify ability to meet short-term debt.
Liabilities grew 58.7% — significant increase in debt or obligations, assess impact on financial flexibility.
Current assets grew 51.1% — improving short-term liquidity or inventory/receivables build.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →